{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T10:18:51Z","timestamp":1713003531405},"reference-count":25,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.neulet.2006.05.015","type":"journal-article","created":{"date-parts":[[2006,6,20]],"date-time":"2006-06-20T07:26:11Z","timestamp":1150788371000},"page":"103-106","source":"Crossref","is-referenced-by-count":18,"title":["Effects of treatment with acamprosate on \u03b2-endorphin plasma concentration in humans with high alcohol preference"],"prefix":"10.1016","volume":"404","author":[{"given":"Falk","family":"Kiefer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Otte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Nakovics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neulet.2006.05.015_bib1","first-page":"67","article-title":"Disturbance of the stress response. The role of the HPA axis during alcohol withdrawal and abstinence","volume":"22","author":"Adinoff","year":"1998","journal-title":"Alcohol Health Res. World"},{"issue":"7","key":"10.1016\/j.neulet.2006.05.015_bib2","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/01.ALC.0000176356.97620.84","article-title":"Suppression of the HPA axis stress-response: implications for relapse","volume":"29","author":"Adinoff","year":"2005","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neulet.2006.05.015_bib3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0031-6989(84)80060-0","article-title":"The calcium antagonist nimodipine increases beta-endorphin release from rat hypophysis through an action on adrenal glands. An \u201cin vivo\u201d and \u201cin vitro\u201d study","volume":"16","author":"Costa","year":"1984","journal-title":"Pharmacol. Res. Commun."},{"issue":"11","key":"10.1016\/j.neulet.2006.05.015_bib4","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1097\/01.alc.0000187599.17786.4a","article-title":"Differences in the peripheral levels of beta-endorphin in response to alcohol and stress as a function of alcohol dependence and family history of alcoholism","volume":"29","author":"Dai","year":"2005","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neulet.2006.05.015_bib5","series-title":"Drugs for Relapse Prevention of Alcoholism","article-title":"Acamprosate: preclinical data","author":"De Witte","year":"2005"},{"key":"10.1016\/j.neulet.2006.05.015_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/oxfordjournals.alcalc.a045093","article-title":"Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour","volume":"26","author":"Gewiss","year":"1991","journal-title":"Alcohol Alcohol."},{"issue":"3","key":"10.1016\/j.neulet.2006.05.015_bib7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/archpsyc.1996.01830030072011","article-title":"Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism","volume":"53","author":"Gianoulakis","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.neulet.2006.05.015_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpsyc.62.1.57","article-title":"Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil","volume":"62","author":"Heinz","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2006.05.015_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00213-002-1118-y","article-title":"Is withdrawal-induced anxiety in alcoholism based on \u03b2-endorphin deficiency?","volume":"162","author":"Kiefer","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2006.05.015_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1024\/suc.2003.49.6.342","article-title":"Die NACALM-Studie: Wirksamkeit, Vertraglichkeit, outcome","volume":"49","author":"Kiefer","year":"2003","journal-title":"Sucht"},{"key":"10.1016\/j.neulet.2006.05.015_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","article-title":"Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study","volume":"60","author":"Kiefer","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.neulet.2006.05.015_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2005.09.028","article-title":"New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence","volume":"526","author":"Kiefer","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"3\u20134","key":"10.1016\/j.neulet.2006.05.015_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1369-1600.2004.tb00534.x","article-title":"Neuroendocrine pathways of addictive behaviour","volume":"9","author":"Kiefer","year":"2004","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neulet.2006.05.015_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(98)00550-3","article-title":"The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats","volume":"252","author":"Kratzer","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2006.05.015_bib15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1360-0443.1995.tb01088.x","article-title":"Acamprosate in alcohol dependence: how does it work?","volume":"90","author":"Littleton","year":"1995","journal-title":"Addiction"},{"key":"10.1016\/j.neulet.2006.05.015_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.ALC.0000108656.81563.05","article-title":"The efficacy of acamprosate in maintaining abstinence in alcohol-dependent individuals: results of a meta-analysis","volume":"28","author":"Mann","year":"2004","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"8","key":"10.1016\/j.neulet.2006.05.015_bib17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2165\/00023210-200519080-00005","article-title":"The opioidergic-alcohol link: implications for treatment","volume":"19","author":"Modesto-Lowe","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neulet.2006.05.015_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002130100919","article-title":"Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis","volume":"160","author":"O\u2019Malley","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2006.05.015_bib19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0028-3908(01)00008-9","article-title":"The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801","volume":"40","author":"Rammes","year":"2001","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neulet.2006.05.015_bib20","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/01.alc.0000174913.60384.e8","article-title":"Role of the endogenous opioid system on the neuropsychopharmacological effects of ethanol: new insights about an old question","volume":"29","author":"Sanchis-Segura","year":"2005","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"4","key":"10.1016\/j.neulet.2006.05.015_bib21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1530-0277.1988.tb00228.x","article-title":"Reactions to alcohol in sons of alcoholics and controls","volume":"12","author":"Schuckit","year":"1988","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neulet.2006.05.015_bib22","first-page":"489","article-title":"The involvement of GABA (A) receptors in the control of GnRH and betaendorphin release, and catecholaminergic activity in ventromedialinfundibular region of hypothalamus in anestrous ewes","volume":"52","author":"Tomaszewska-Zaremba","year":"2001","journal-title":"J. Physiol. Pharmacol."},{"issue":"2","key":"10.1016\/j.neulet.2006.05.015_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/alcalc\/34.2.197","article-title":"A three-pathway psychobiological model of craving for alcohol","volume":"34","author":"Verheul","year":"1999","journal-title":"Alcohol Alcohol."},{"issue":"1","key":"10.1016\/j.neulet.2006.05.015_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2005.06.032","article-title":"Changes in the beta-endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference","volume":"388","author":"Zalewska-Kaszubska","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2006.05.015_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(93)90682-8","article-title":"Acamprosate (calcium acetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors","volume":"231","author":"Zeise","year":"1993","journal-title":"Eur. J. Pharmacol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394006004940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394006004940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T08:54:21Z","timestamp":1555664061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394006004940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":25,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0304394006004940"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2006.05.015","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}